Paradigm Change in First-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

SIMPLE SUMMARY: Immunotherapy has made a breakthrough in the treatment of patients with recurrent and/or metastatic head and neck squamous cell carcinoma in the second line setting with anti-PD-1/PD-L1 immune checkpoint inhibitors. Furthermore, the KEYNOTE-048 study has established a new standard of...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cancers (Basel)
Huvudupphovsmän: Borcoman, Edith, Marret, Gregoire, Le Tourneau, Christophe
Materialtyp: Artigo
Språk:Inglês
Publicerad: MDPI 2021
Ämnen:
Review
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC8197177/
https://ncbi.nlm.nih.gov/pubmed/34073885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13112573
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk